Bryn Mawr Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.37M | Buy |
8,305
+158
| +2% | +$64.1K | 0.18% | 106 |
|
|
2025
Q1 | $4.05M | Sell |
8,147
-1,918
| -19% | -$954K | 0.24% | 95 |
|
|
2024
Q4 | $5.24M | Sell |
10,065
-1,117
| -10% | -$581K | 0.28% | 80 |
|
|
2024
Q3 | $6.92M | Sell |
11,182
-303
| -3% | -$187K | 0.37% | 67 |
|
|
2024
Q2 | $6.35M | Sell |
11,485
-392
| -3% | -$217K | 0.35% | 68 |
|
|
2024
Q1 | $6.9M | Buy |
11,877
+1,768
| +17% | +$1.03M | 0.39% | 65 |
|
|
2023
Q4 | $5.37M | Buy |
10,109
+1,243
| +14% | +$660K | 0.33% | 78 |
|
|
2023
Q3 | $4.49M | Buy |
8,866
+812
| +10% | +$411K | 0.29% | 78 |
|
|
2023
Q2 | $4.2M | Sell |
8,054
-492
| -6% | -$257K | 0.39% | 66 |
|
|
2023
Q1 | $4.93M | Sell |
8,546
-151
| -2% | -$87K | 0.51% | 56 |
|
|
2022
Q4 | $4.79M | Buy |
8,697
+5,799
| +200% | +$3.19M | 0.52% | 55 |
|
|
2022
Q3 | $1.47M | Sell |
2,898
-2
| -0.1% | -$1.01K | 0.52% | 48 |
|
|
2022
Q2 | $1.58M | Sell |
2,900
-48
| -2% | -$26.1K | 0.52% | 49 |
|
|
2022
Q1 | $1.74M | Buy |
+2,948
| New | +$1.74M | 0.49% | 54 |
|